Protagonist Therapeutics Inc (NAS:PTGX) Stock News, Headlines & Updates
Protagonist Therapeutics Inc Stock News from GuruFocus
- 1
Jun 14, 2024
Protagonist Reports Updated Long Term Results from Rusfertide Phase 2 REVIVE Study at the EHA2024 Congress Showing Durable Hematocrit Control
ACCESSWIRE • 3:00am
May 31, 2024
Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2024
ACCESSWIRE • 7:00am
May 15, 2024
Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 REVIVE Study Open Label Extension at the European Hematology Association 2024 Congress
ACCESSWIRE • 7:00pm
May 08, 2024
Protagonist Therapeutics Inc (PTGX) Surpasses Q1 Revenue Estimates with Strategic Collaborations
GuruFocus Research • 7:04pm
Protagonist Therapeutics to Participate in the Citizens JMP Life Sciences Conference and the Capital One 1st Annual Biotech/Biopharma Disruptors Event
ACCESSWIRE • 7:00pm
Protagonist Reports First Quarter 2024 Financial Results and Provides Corporate Update
ACCESSWIRE • 7:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news